The phrase "and allowed development of" is correct and usable in written English.
It can be used when discussing the facilitation or permission of growth or progress in a particular area or field.
Example: "The new policy was implemented, and allowed development of innovative technologies in the industry."
Alternatives: "and enabled the growth of" or "and permitted the advancement of".
Structural studies elucidate the mechanism governing the Atg8 binding potency and selectivity of the peptides, reveal a general Atg8-binding sequence motif, and allow development of a more GABARAP-selective inhibitory peptide.
These molecules can be used with Cas9 for in vitro site-specific nuclease purposes, provide a novel platform for cellular manipulation and allow development of more stable and cost-effective reagents for Cas9 applications.
Further studies using different ion energies and fluence may further explain the role of electronic energy loss on these devices and allow development of precise control of the blocking layer.
Early recognition will also help assess the true affect of BMT on the evolution of ON and allow development of interventions to ameliorate ON progression and maintain joint function.
Administration of a fixed dose of s.c. trastuzumab would permit less complex handling, avoid the need for dose calculation, reduce the potential for dosing errors, and allow development of a single-use injection device.
The potential for linkage to other national registries in primary and secondary care is being explored in order to enrich the dataset and allow development of a longitudinal patient record.
The organism functionality parameters on admission to ICU reflect changes which have occurred during the surgical procedure and allow development of more precise postoperative surgical risk models than scales using only preoperative parameters.
This calls into question the need for deployment of metal stents in cases where PCI does not result in dissection of the vessel and allows development of biomimetic polymers that can be used to temporarily repave the vascular surface to protect the vessel from platelet binding and the subsequent recruitment of neutrophils and monocytes.
A dose-escalation study design was selected to mimic nalbuphine use in uremic pruritus patients in subsequent clinical efficacy studies where patients would start at a low dose to minimize common opioid AEs such as nausea and vomiting and allow development of some tolerance to these particular AEs.
